Détail de la notice
Titre du Document
In vitro studies indicate that miquelianin (Quercetin 3-o-β-d-glucuronopyranoside) is able to reach the CNS from the small intestine
Auteur(s)
JUERGENLIEMK Guido ; BOJE Kerstin ; HUEWEI Sabine ; ...
Résumé
Miquelianin (quercetin 3-O-β-D-glucuronopyranoside) is one of the flavonoids of St. John's wort (Hypericum perforatum L.) whose antidepressant activity has been shown by the forced swimming test, an in vivo pharmacological model with rats. However, nothing is known about its ability to reach the CNS after oral administration. We examined the pathway of miquelianin from the small intestine to the central nervous system using three in vitro membrane barrier cell systems. In the Caco-2 cell line, miquelianin showed a higher uptake (1.93 ± 0.9 pmol × min-1 x cm-2) than hyperoside (quercetin 3-O-β-D-galactopyranoside; 0.55 ± 0.18 pmol × min-1 × cm-2) and quercitrin (quercetin 3-O-α-L-rhamnopyranoside; 0.22 ± 0.08 pmol × min-1 × cm-2). The permeability coefficient of miquelianin (Pc = 0.4 ± 0.19 × 10-6cm/ sec) was in the range of orally available drugs assuming sufficient absorption from the small intestine. Uptake and permeability of the examined compounds was increased by the MRP-2 inhibitor MK-571 indicating a backwards transport by this membrane protein. Porcine cell cultures of brain capillary endothelial cells were used as a model of the blood-brain barrier (bbb) and epithelial cells of the plexus chorioidei as a model of the blood-CSF barrier (bcb). Results indicate no active transport in one direction. Although moderate, the permeability coefficients (bbb: Pc = 1.34 ± 0.05 × 10-6cm/sec; bcb: Pc
Editeur
Thieme; Thieme
Identifiant
PMID : 14735439 ISSN : 0032-0943 CODEN : PLMEAA
Source
Planta medica A. 2003, vol. 69, n° 11, pp. 1013-1017 [5 pages] [bibl. : 22 ref.]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :